A citation-based method for searching scientific literature

Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J Dirk Iglehart, Nadine Tung, Paula D Ryan, Judy E Garber, Daniel P Silver, Zoltan Szallasi, Andrea L Richardson. Cancer Discov 2012
Times Cited: 296



S Loibl, K E Weber, K M Timms, E P Elkin, E Hahnen, P A Fasching, B Lederer, C Denkert, A Schneeweiss, S Braun, C T Salat, M Rezai, J U Blohmer, D M Zahm, C Jackisch, B Gerber, P Klare, S Kümmel, C Schem, S Paepke, R Schmutzler, K Rhiem, S Penn, J Reid, V Nekljudova, A-R Hartman, G von Minckwitz, M Untch. Ann Oncol 2018
Times Cited: 122




List of shared articles



Times cited

Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining.
Dale A Ramsden, Juan Carvajal-Garcia, Gaorav P Gupta. Nat Rev Mol Cell Biol 2022
17

Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score.
C Benedikt Westphalen, Alexander D Fine, Fabrice André, Shridar Ganesan, Volker Heinemann, Etienne Rouleau, Clare Turnbull, Luis Garcia Palacios, Jorge-Antonio Lopez, Ethan S Sokol,[...]. Clin Cancer Res 2022
10

qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer.
Ke Zuo, Xiaoying Yuan, Xizi Liang, Xiangjie Sun, Shujin Liu, Philip P Connell, Xingmin Li, Wentao Yang. Breast Cancer Res Treat 2022
1

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
Loïck Galland, Elise Ballot, Hugo Mananet, Romain Boidot, Julie Lecuelle, Juliette Albuisson, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai,[...]. NPJ Breast Cancer 2022
0

Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Xingkui Tang, Yukun Lin, Jialin He, Xijun Luo, Junjie Liang, Xianjun Zhu, Tao Li. World J Surg Oncol 2022
0


Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis.
Liulu Zhang, Yuanqi Chen, Min-Yi Cheng, Xiaosheng Zhuang, Jiachen Zou, Dannuo Wei, Ying-Yi Lin, Yi Zhang, Kun Wang. Ther Adv Med Oncol 2022
0

The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair.
Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, Ana Isabel Ballesteros, Gloria Marquina, Iván González-Díaz, Ramon Colomer, Nuria Romero-Laorden. Cancers (Basel) 2022
0


Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapy.
Rayhaan M M Ali, Stuart A McIntosh, Kienan I Savage. Genes Chromosomes Cancer 2021
8

Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity.
Sandra van Wilpe, Sofie H Tolmeijer, Rutger H T Koornstra, I Jolanda M de Vries, Winald R Gerritsen, Marjolijn Ligtenberg, Niven Mehra. Cancers (Basel) 2021
11

The advance of adjuvant treatment for triple-negative breast cancer.
Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao, Keda Yu. Cancer Biol Med 2021
2